Risk factors for lower adherence to epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer: A nationwide retrospective cohort study in Japan
{{output}}
Introduction: The prognosis of patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer (EGFR-m-NSCLC) has improved with the introduction of oral EGFR- tyrosine kinase inhibitor (TKI). Lower adh... ...
